18 Dec 2018

Oral typhoid vaccine updated Summary of Product Characteristics (SPC)

Vivotif® SPC updated to provide three years protection and minimum age for vaccination reduced to five years Oral typhoid vaccine updated Summary of Product Characteristics (SPC)
The Summary of Product Characteristics (SPC) for oral typhoid vaccine, Vivotif® has been updated [1]. In line with Public Health England’s ‘Green Book’ Immunisation against infectious disease, the Vivotif® SPC now indicates revaccination at three years for travellers at continued risk [1,2]. Previously Vivotif’s licence covered one year of protection for travellers.
 
The updated Vivotif® SPC now indicates vaccination for adults and children aged five years and older [1]. Previously the marketing authority (licence) covered use in children from six years of age. Guidance on the use of Vivotif® in those aged five years is awaited from the Joint Committee on Vaccination and Immunisation.
 
Vivotif® vaccination is taken orally; the dose is one capsule taken on alternate days (three capsules in total). Each capsule should be taken with cold or lukewarm water (temperature not more than 37°C) on an empty stomach and at least one hour before the next meal [1]. Note that the vaccine capsule should not be chewed and should be swallowed whole as soon as possible after placing in the mouth [1]. This may be difficult for some young children.
 
Health professionals should ensure they are familiar with the Summary of Product Characteristics before prescribing the vaccine.

Resources

Public Health England updated vaccine incident guidance

PHE have published updated guidance on responding to errors in vaccine storage, handling or administration Read more

New team member

NaTHNaC welcomes Dr MacGregor Read more

‘Current aspects of travel health’ course Dec 2019

A single day update for health professionals will be held on 12 December in London Read more

Ghana: new outbreak of circulating vaccine derived poliovirus (cVDPV)

The first case circulating vaccine derived poliovirus type 2 (cVDPV2) has been reported in Ghana Read more

Ebola virus disease (EVD) in Democratic Republic of Congo and update to Uganda

The Ebola virus disease (EVD) outbreak continues in eastern Democratic Republic of Congo (DRC) Read more
Back to Top

VIEW FULL INDEX